Literature DB >> 27411904

Autoimmunity: Interferon α or β: which is the culprit in autoimmune disease?

Mary K Crow1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27411904     DOI： 10.1038/nrrheum.2016.117

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.

Authors:  S D Der; A Zhou; B R Williams; R H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

2.  Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures.

Authors:  Laurent Chiche; Noémie Jourde-Chiche; Elizabeth Whalen; Scott Presnell; Vivian Gersuk; Kristen Dang; Esperanza Anguiano; Charlie Quinn; Stéphane Burtey; Yvon Berland; Gilles Kaplanski; Jean-Robert Harle; Virginia Pascual; Damien Chaussabel
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

Review 3.  Type I interferon in the pathogenesis of lupus.

Authors:  Mary K Crow
Journal:  J Immunol       Date:  2014-06-15       Impact factor: 5.422

4.  Type I interferon is a therapeutic target for virus-induced lethal vascular damage.

Authors:  Roberto Baccala; Megan J Welch; Rosana Gonzalez-Quintial; Kevin B Walsh; John R Teijaro; Anthony Nguyen; Cherie T Ng; Brian M Sullivan; Alessandro Zarpellon; Zaverio M Ruggeri; Juan Carlos de la Torre; Argyrios N Theofilopoulos; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-02       Impact factor: 11.205

5.  Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.

Authors:  Brandon W Higgs; Zheng Liu; Barbara White; Wei Zhu; Wendy I White; Chris Morehouse; Philip Brohawn; Peter A Kiener; Laura Richman; David Fiorentino; Steven A Greenberg; Bahija Jallal; Yihong Yao
Journal:  Ann Rheum Dis       Date:  2011-07-28       Impact factor: 19.103

Review 6.  Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation.

Authors:  Jacob Piehler; Christoph Thomas; K Christopher Garcia; Gideon Schreiber
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

7.  Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus.

Authors:  Yihong Yao; Brandon W Higgs; Chris Morehouse; Melissa de Los Reyes; Wendy Trigona; Philip Brohawn; Wendy White; Jianliang Zhang; Barbara White; Anthony J Coyle; Peter A Kiener; Bahija Jallal
Journal:  Hum Genomics Proteomics       Date:  2009-11-17

8.  Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases.

Authors:  David Wong; Bory Kea; Rob Pesich; Brandon W Higgs; Wei Zhu; Patrick Brown; Yihong Yao; David Fiorentino
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

9.  Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.

Authors:  Munther Khamashta; Joan T Merrill; Victoria P Werth; Richard Furie; Kenneth Kalunian; Gabor G Illei; Jorn Drappa; Liangwei Wang; Warren Greth
Journal:  Ann Rheum Dis       Date:  2016-03-23       Impact factor: 19.103

10.  Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases.

Authors:  Tamarah D de Jong; Saskia Vosslamber; Elise Mantel; Sander de Ridder; John G Wesseling; Tineke C T M van der Pouw Kraan; Cyra Leurs; Harald Hegen; Florian Deisenhammer; Joep Killestein; Ingrid E Lundberg; Jiri Vencovsky; Mike T Nurmohamed; Dirkjan van Schaardenburg; Irene E M Bultink; Alexandre E Voskuyl; D Michiel Pegtel; Conny J van der Laken; Johannes W J Bijlsma; Cornelis L Verweij
Journal:  Arthritis Res Ther       Date:  2016-02-17       Impact factor: 5.156
  10 in total
  13 in total

1.  Oligoadenylate-Synthetase-Family Protein OASL Inhibits Activity of the DNA Sensor cGAS during DNA Virus Infection to Limit Interferon Production.

Authors:  Arundhati Ghosh; Lulu Shao; Padmavathi Sampath; Baoyu Zhao; Nidhi V Patel; Jianzhong Zhu; Bharat Behl; Robert A Parise; Jan H Beumer; Roderick J O'Sullivan; Neal A DeLuca; Stephen H Thorne; Vijay A K Rathinam; Pingwei Li; Saumendra N Sarkar
Journal:  Immunity       Date:  2019-01-08       Impact factor: 31.745

Review 2.  Absent in Melanoma 2 proteins in SLE.

Authors:  Divaker Choubey; Ravichandran Panchanathan
Journal:  Clin Immunol       Date:  2017-01-03       Impact factor: 3.969

Review 3.  Autoreactive B cells in SLE, villains or innocent bystanders?

Authors:  Jennie A Hamilton; Hui-Chen Hsu; John D Mountz
Journal:  Immunol Rev       Date:  2019-10-21       Impact factor: 12.988

4.  New Perspectives in Rheumatology: May You Live in Interesting Times: Challenges and Opportunities in Lupus Research.

Authors:  Iñaki Sanz
Journal:  Arthritis Rheumatol       Date:  2017-06-16       Impact factor: 10.995

Review 5.  Established and Emerging Immunological Complications of Biological Therapeutics in Multiple Sclerosis.

Authors:  Babak Soleimani; Katy Murray; David Hunt
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.606

Review 6.  Innate Immune Dysregulation in the Development of Cardiovascular Disease in Lupus.

Authors:  Gantsetseg Tumurkhuu; Erica Montano; Caroline Jefferies
Journal:  Curr Rheumatol Rep       Date:  2019-07-23       Impact factor: 4.592

7.  Cutting Edge: Intracellular IFN-β and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells.

Authors:  Jennie A Hamilton; Qi Wu; PingAr Yang; Bao Luo; Shanrun Liu; Jun Li; Alexa L Mattheyses; Ignacio Sanz; W Winn Chatham; Hui-Chen Hsu; John D Mountz
Journal:  J Immunol       Date:  2018-09-10       Impact factor: 5.422

Review 8.  Interferon-stimulated genes: new platforms and computational approaches.

Authors:  Richard Green; Reneé C Ireton; Michael Gale
Journal:  Mamm Genome       Date:  2018-07-07       Impact factor: 3.224

Review 9.  Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases.

Authors:  Bas C Mourik; Erik Lubberts; Jurriaan E M de Steenwinkel; Tom H M Ottenhoff; Pieter J M Leenen
Journal:  Front Immunol       Date:  2017-04-05       Impact factor: 7.561

Review 10.  Matrix Metalloproteases as Influencers of the Cells' Social Media.

Authors:  Daniel Young; Nabangshu Das; Anthonia Anowai; Antoine Dufour
Journal:  Int J Mol Sci       Date:  2019-08-07       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.